I. Yamamoto

发表

Fracture simulation of the femoral bone using the finite-element method: How a fracture initiates and proceeds

T. Ota, I. Yamamoto, R. Morita, 1999, Journal of Bone and Mineral Metabolism.

End plate of the discovertebral joint: degenerative change in the elderly adult.

K. Torizuka, I. Yamamoto, J. Aoki, 1987, Radiology.

Relationship between skeletal uptake of99mTc-HMDP and bone mineral density in elderly women

M. Takada, T. Ota, I. Yamamoto, 1998, Annals of nuclear medicine.

Urinary pyridinoline and deoxypyridinoline as bone metabolic markers in predicting therapeutic effects of estrogen and alfacalcidol in women with osteoporosis

I. Yamamoto, R. Morita, Z. Zhan, 1999, Journal of Bone and Mineral Metabolism.

Three-dimensional bone scintigraphy using volume-rendering technique and SPECT.

K. Murata, T. Suzuki, T. Ota, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Vertebral bone mineral measurement: A comparative study between quantitative computed tomography and dual X-ray absorptiometry

M. Takada, I. Yamamoto, R. Morita, 1994, Journal of Bone and Mineral Metabolism.

Bone mineral measurement by CT apparatus with simultaneous use of reference phantom: Error factors and clinical evaluation

T. Yamamuro, I. Yamamoto, H. Okumura, 1988, Journal of Bone and Mineral Metabolism.

Bone fragility induced by x-ray irradiation in relation to cortical bone-mineral content

I. Yamamoto, R. Morita, H. Kimura, 1998, Acta radiologica.

[Clinical studies using measurement of N-telopeptides of type 1 collagen (NTx) in patients with bone metastasis--comparison with bone scintigraphy and other metabolic bone markers].

I. Yamamoto, R. Morita, T. Sone, 1995, Kaku igaku. The Japanese journal of nuclear medicine.

Adenylate cyclase activation and competitive binding with renal tissue using synthetic eel calcitonin analog and its fragments.

M. Fukunaga, K. Torizuka, I. Yamamoto, 1981, Endocrinology.

Transforming growth factor β modulates proliferation of osteoblastic cells: Relation to its effect on receptor levels for epidermal growth factor

T. Yamamuro, I. Yamamoto, H. Okumura, 1989 .

Avid uptake of gallium-67 in multiple myeloma. An additional indicator of the aggressive phase.

K. Torizuka, I. Yamamoto, H. Uchino, 1987, Clinical nuclear medicine.

Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol

K. Kaneda, K. Takaoka, Y. Sugioka, 2007, Journal of Bone and Mineral Metabolism.

Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia.

K. Torizuka, I. Yamamoto, R. Morita, 1985, The Journal of clinical endocrinology and metabolism.

[Studies on the measurement of vitamin D derivatives in human plasma. I. A competitive protein binding assay for 25-hydroxyvitamin D in plasma (author's transl)].

M. Fukunaga, K. Torizuka, I. Yamamoto, 1981, Nihon Naibunpi Gakkai zasshi.

Human calcitonin gene-related peptide possesses weak inhibitory potency of bone resorptionin vitro

K. Torizuka, A. Otaka, N. Fujii, 1986, Calcified Tissue International.

Chronic intramedullary infusion of interleukin-1α increases bone mineral content in rats

M. Takada, I. Yamamoto, R. Morita, 1994, Calcified Tissue International.

Diagnostic validity of bone metabolic markers for bone metastasis.

M. Takada, I. Yamamoto, R. Morita, 1997, Endocrine journal.

[The effects of oral doses of 1, 25-dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 on intestinal calcium absorption and serum 1, 25-dihydroxyvitamin D level: a study in healthy adults and in postmenopausal osteoporosis].

M. Fukunaga, T. Mukai, K. Torizuka, 1982, Nihon Naibunpi Gakkai zasshi.

Competitive protein binding assay for 1,25-dihydroxy-vitamin D in human plasma.

M. Fukunaga, K. Torizuka, I. Yamamoto, 1978, Endocrinologia japonica.

[Studies on the measurement of vitamin D derivatives in human plasma. II. A fundamental study on the multiple assay for vitamin D derivatives (author's transl)].

M. Fukunaga, K. Torizuka, I. Yamamoto, 1981, Nihon Naibunpi Gakkai zasshi.

Interaction of human parathyroid hormone-related peptide with parathyroid hormone receptors in clonal rat osteosarcoma cells.

N. Fujii, I. Yamamoto, H. Yajima, 1988, The Journal of biological chemistry.

Osteoclast‐mediated osteolysis in bone metastasis from renal cell carcinoma

I. Yamamoto, J. Aoki, N. Kitamura, 1988, Cancer.

Estimation of bone mineral density and bone loss by means of bone metabolic markers in postmenopausal women.

I. Yamamoto, R. Morita, Y. Kigami, 1995, Endocrine journal.

Evidence that factors other than 1,25 dihydroxyvitamin D may play a role in augmenting intestinal calcium absorption in patients with primary hyperparathyroidism

M. Fukunaga, K. Torizuka, I. Yamamoto, 1986, Calcified Tissue International.

Reactive endosteal bone formation

T. Sone, K. Torizuka, I. Yamamoto, 2004, Skeletal Radiology.

Scintigraphic diagnosis of primary and metastatic bone tumour by technetium-99m diphosphonate

K. Hamamoto, K. Torizuka, I. Yamamoto, 1978, International Orthopaedics.

Accumulation of 99mTc-pyrophosphate in a muscle hernia of the thigh

M. Fukunaga, K. Torizuka, I. Yamamoto, 2004, European Journal of Nuclear Medicine.

Accumulation of 201TI-Chloride in a Parathyroid Adenoma

Y. Yonekura, T. Fujita, K. Torizuka, 1979, Clinical nuclear medicine.

Circulating 1,25-dihydroxyvitamin D concentrations in patients with renal cell carcinoma-associated hypercalcemia are rarely suppressed.

K. Torizuka, J. Kawamura, I. Yamamoto, 1987, The Journal of clinical endocrinology and metabolism.

A Family of Autosomal Dominant Osteoscierosis

K. Torizuka, Y. Yasuda, I. Yamamoto, 1987 .

Histological Findings of Paget's Disease of Bone

M. Fukunaga, K. Torizuka, I. Yamamoto, 1986 .

Intrapancreatic accessory spleen diagnosed by technetium-99m heat-damaged red blood cell SPECT.

M. Tei, T. Ota, I. Yamamoto, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Chronic Intramedullary Infusion Stimulates Bone Formation Both in the Periosteum of in Prostaglandin E 2 the Bone Marrow and

M. Takada, I. Yamamoto, Y. Kigami, 2006 .

Chronic intramedullary infusion of prostaglandin E2 stimulates bone formation both in the bone marrow and in the periosteum.

M. Takada, I. Yamamoto, R. Morita, 1995, Endocrine journal.

T. Ota, I. Yamamoto, R. Morita, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radioimmunoassay for human calcitonin employing synthetic calcitonin M: its clinical application.

M. Fukunaga, K. Torizuka, I. Yamamoto, 1975, Endocrinologia japonica.

[Studies on the measurement of vitamin D derivatives in human plasma. III. Plasma concentrations of vitamin D derivatives in various diseases (author's transl)].

M. Fukunaga, K. Torizuka, I. Yamamoto, 1982, Nihon Naibunpi Gakkai zasshi.

[Aluminum associated bone disease in patients undergoing long-term hemodialysis].

K. Torizuka, I. Yamamoto, J. Aoki, 1986, Nihon Naibunpi Gakkai zasshi.

Comparison of various biochemical measurements with bone mineral densitometry and quantitative ultrasound for the assessment of vertebral fracture

M. Takada, I. Yamamoto, R. Morita, 2000, Journal of Bone and Mineral Metabolism.

Case report 429

K. Torizuka, I. Yamamoto, H. Uchino, 2004, Skeletal Radiology.

Comparison of bone mineral density at various skeletal sites with quantitative ultrasound parameters of the calcaneus for assessment of vertebral fractures

M. Takada, T. Ota, I. Yamamoto, 1999, Journal of Bone and Mineral Metabolism.

Changes in sex hormones and calcium regulating hormones with reference to bone mass associated with aging.

M. Fukunaga, K. Torizuka, T. Aso, 1979, Endocrinologia Japonica.

[Skeletal nuclear medicine].

I. Yamamoto, 1995, Kaku igaku. The Japanese journal of nuclear medicine.

Episodic fluctuation in serum intact parathyroid hormone concentration in men.

E. Tadamura, I. Yamamoto, N. Kitamura, 1990, The Journal of clinical endocrinology and metabolism.

Fractures in patients with myopathies.

K. Torizuka, I. Yamamoto, R. Morita, 1979, Archives of Physical Medicine and Rehabilitation.

Quantitative ultrasound for the assessment of bone status

M. Takada, I. Yamamoto, R. Morita, 2010, Osteoporosis International.

Two optimal prefilter cutoff frequencies needed for SPECT images of myocardial perfusion in a one-day protocol.

R Morita, I Yamamoto, M. Takada, 1997, Journal of nuclear medicine technology.

Some problems of dual-energy x-ray absorptiometry in the clinical use

K. Kaneda, M. Fukunaga, H. Orimo, 2005, Osteoporosis International.

Early changes in bone mineral content caused by acute irradiation are not observed after daily fractionation: A study by dual-energy X-ray absorptiometry

I. Yamamoto, R. Morita, H. Kimura, 2006, Journal of Bone and Mineral Metabolism.

[Recent development and clinical application of bone mineral measurements].

M. Takada, I. Yamamoto, R. Morita, 1998, Nihon rinsho. Japanese journal of clinical medicine.

Co-purification of bone resorbing activity and adenylate cyclase stimulating activity from human tumours associated with the humoral hypercalcaemia of malignancy.

K. Torizuka, I. Yamamoto, R. Morita, 1987, Acta endocrinologica.